Saidal, Novo Nordisk Forge a Strategic Alliance to Advance Pharmaceutical Innovation in Algeria
✍️ BY: Dr. Hana Saada
Algiers – October 2025 – In a move that underscores Algeria’s growing role in the regional pharmaceutical landscape, the Saidal Group, a leading national player in the pharmaceutical industry, and Novo Nordisk Algérie, the local subsidiary of the Danish global giant specializing in diabetes and obesity treatments, have formalized a strategic memorandum of understanding to bolster the production and distribution of innovative therapies in Algeria.
The signing ceremony took place at the headquarters of Saidal Group in Algiers, in the presence of Mrs. Nabila Benygzer née Ouaret, Chief Executive Officer of Saidal, and Mr. Hamza Benharkat, Managing Director of Novo Nordisk Algérie, alongside senior executives from both organizations.
This partnership represents a significant leap forward in Algerian-Danish pharmaceutical cooperation, setting the stage for joint development of next-generation molecules, including innovative insulin formulations, and paving the way for the establishment of a “full-process” aseptic production line within Algeria. The agreement thus aligns perfectly with the country’s strategy to strengthen its domestic pharmaceutical capabilities and ensure long-term health sovereignty.
Anchored in a shared vision of sustainable innovation, the collaboration between Saidal and Novo Nordisk is grounded in technology transfer and expertise exchange—key components in enhancing Algeria’s local manufacturing potential and positioning it as a hub for advanced biopharmaceutical production in Africa and the Mediterranean region.
By combining Novo Nordisk’s global excellence in research, development, and biotechnological innovation with Saidal’s extensive industrial experience and established production infrastructure, the partnership aspires to deliver safe, effective, and cutting-edge treatments to Algerian patients. This will not only expand access to life-saving medications but also elevate national standards to align with the most rigorous international benchmarks.
Ultimately, this alliance embodies a forward-looking commitment to innovation, self-reliance, and patient well-being, reflecting Algeria’s determination to solidify its pharmaceutical sovereignty and affirm its place among nations investing in the future of healthcare and scientific excellence.
📡🌍 | About Dzair Tube Media Group | 🌍📡
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
📰 Dzair Tube is a trailblazer in Algerian digital journalism, delivering high-quality content in Arabic, French, and English. With more than 📈 500,000 daily clicks, it ranks among the most influential media platforms in the country.
🏆 Awarded the President of the Republic’s Prize for Professional Journalist in the Electronic Press category (🗓 October 22, 2022), Dzair Tube is widely recognized for its editorial excellence and integrity.
📱 Massive Digital Reach:
🔴 350,000+ YouTube subscribers
🔵 6 million+ followers across Facebook pages
📸 70,000+ Instagram followers
🎥 Operating from state-of-the-art studios, Dzair Tube broadcasts rich and diverse programming, including:
🗞 News | ⚽ Sports | 🎭 Entertainment | 🕌 Religion | 🎨 Culture
🗣️ Featuring interactive talk shows and exclusive interviews with prominent figures from politics, business, arts, and more, Dzair Tube serves as a key platform for public discourse and civic engagement.
📰 Its print sports daily, “Dzair Sport,” enjoys over 50,000 daily downloads via the official website—further cementing the platform’s multimedia leadership.
🎖️ Honored with the Media Leadership Award by the former Minister of Communication, Mohamed Laâgab, and celebrated at the Hilals of the Television awards, Dzair Tube continues to lead with innovation, influence, and impact.
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
🌐 Stay Connected:
🔗 Website: www.dzair-tube.dz
🔗 English: www.dzair-tube.dz/en
📲 Follow us on Facebook | Instagram | YouTube
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
